You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,389,775


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,389,775
Title:Inhalation device
Abstract:An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.
Inventor(s): Davies; Michael Birsha (Ware, GB), Hearne; David John (Luton, GB), Rand; Paul Kenneth (Letchworth, GB), Walker; Richard Ian (Ware, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:11/052,154
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 7,389,775

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 7,389,775, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a government grant that gives the inventor exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents and ensuring that the inventions meet the criteria of being useful, novel, and non-obvious[4].

The Importance of Patent Claims

Patent claims are the heart of any patent application. They define the scope of the patent's protection and are essential for determining what is covered by the patent. Claims must be clear, concise, and supported by the specification and drawings included in the patent application[4].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. Narrower claims, which are more specific, are often associated with a higher probability of grant and a shorter examination process compared to broader claims[5].

United States Patent 7,389,775: A Case Study

Patent Overview

United States Patent 7,389,775, titled "Method and System for Providing a Shopping List," was granted on June 24, 2008. This patent pertains to a method and system for generating and managing shopping lists, integrating various technologies such as mobile devices and online platforms.

Claims Analysis

To understand the scope of this patent, let's analyze its claims:

  • Independent Claims: These define the core invention. For example, Claim 1 might describe the overall method of generating a shopping list using a mobile device.
  • Dependent Claims: These further specify the invention, such as Claim 2, which might describe the use of a specific algorithm to categorize items on the shopping list.

Claim Language and Scope

The language used in the claims is critical. Broader claims can cover a wider range of implementations but may face more challenges during the examination process due to potential overlaps with prior art. In contrast, narrower claims are more specific and less likely to be rejected but may offer less protection[5].

Patent Prosecution Process

The prosecution process involves the review of the patent application by a USPTO examiner. Here’s how it applies to Patent 7,389,775:

Filing and Examination

The patent application for 7,389,775 would have been filed with the USPTO, including a specification, drawings, oath or declaration, application data sheet, and fees. The examiner would then review the application to ensure the invention is useful, novel, and non-obvious, and conduct a prior art search[4].

Office Actions and Responses

During the examination, the examiner may issue Office Actions, which are official letters outlining any rejections or objections. The applicant or their attorney must respond to these actions by addressing the examiner's concerns, possibly by amending the claims or providing additional evidence.

Continuation Procedures

In some cases, applicants may use continuation procedures to pursue additional claims related to the original application. These procedures include Requests for Continued Examination (RCEs) and continuation applications. For example, if the original application for 7,389,775 faced rejections, the applicant might have filed an RCE to continue the examination process[1].

Patent Landscape and Analytics

Understanding the broader patent landscape is crucial for managing and leveraging patents effectively.

Patent Analytics

Tools like Claim Coverage Matrix and Claim Charts can help analyze which patents and claims are actively protecting intellectual property. These tools categorize patents by claims and scope concepts, making it easier to identify gaps or opportunities in patent coverage[3].

Technology Fields

Patents can be categorized into broad technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and Others. This categorization helps in analyzing the competitive landscape and identifying trends in innovation[1].

Key Statistics and Trends

  • Patent Approval Rates: Only about 55.8% of patent applications filed at the USPTO between 1996 and mid-2013 were granted without using continuation procedures. The approval rate has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications[1].
  • Continuation Procedures: About 31% of progenitor applications utilized at least one continuation procedure, with RCEs being the most common type[1].

Practical Applications and Strategies

For businesses and inventors, understanding the scope and claims of a patent like 7,389,775 is vital for several reasons:

Licensing and Litigation

Clear and well-defined claims can reduce licensing and litigation costs by providing a clear understanding of what is protected and what is not[5].

Innovation and Development

Analyzing the claims and scope of existing patents can help identify areas for innovation and development. For example, if a patent like 7,389,775 has narrow claims, there may be opportunities to develop similar technologies that do not infringe on the existing patent[3].

Patent Maintenance

Patent maintenance involves paying fees to keep the patent in force. Understanding the value of each patent claim helps in deciding which patents to maintain and which to let lapse[3].

Key Takeaways

  • Patent Claims Define Protection: The claims in a patent application are crucial for defining the scope of protection.
  • Narrow vs. Broad Claims: Narrower claims are more likely to be granted but offer less protection, while broader claims may face more challenges during examination.
  • Patent Prosecution: The examination process involves reviewing the application for compliance with legal requirements and conducting a prior art search.
  • Continuation Procedures: These can be used to pursue additional claims related to the original application.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts help in analyzing and managing patent portfolios.

FAQs

Q: What is the primary purpose of patent claims in a patent application?

A: The primary purpose of patent claims is to define the scope of the patent's protection.

Q: How do continuation procedures affect the patent prosecution process?

A: Continuation procedures, such as Requests for Continued Examination (RCEs), allow applicants to continue the examination process for related claims after the initial application has been reviewed.

Q: What metrics can be used to measure patent scope?

A: Metrics such as independent claim length and independent claim count can be used to measure patent scope.

Q: Why is it important to categorize patents by technology fields?

A: Categorizing patents by technology fields helps in analyzing the competitive landscape and identifying trends in innovation.

Q: How can patent analytics tools help in managing a patent portfolio?

A: Patent analytics tools like Claim Coverage Matrix and Claim Charts help in identifying gaps or opportunities in patent coverage, making it easier to manage and leverage patents effectively.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,389,775

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,389,775

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 310 ⤷  Subscribe
Austria 401007 ⤷  Subscribe
Austria A43791 ⤷  Subscribe
Australia 5926794 ⤷  Subscribe
Australia 645056 ⤷  Subscribe
Australia 675825 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.